The impact of lesion morphology and device use on outcome of coronary intervention use in acute coronary syndromes.

被引：0
|
作者：
Zaacks, SM [1 ]
Allen, J [1 ]
Calvin, JE [1 ]
Schaer, GL [1 ]
Klein, LW [1 ]
机构：
[1] Rush Med Coll, Cardiol Sect, Chicago, IL 60612 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1998年 / 46卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：236A / 236A
页数：1
相关论文
共 50 条
  • [1] Management of acute coronary syndromes. Variations in practice and outcome
    Fox, KAA
    Goodman, SG
    Klein, W
    Brieger, D
    Steg, PG
    Dabbous, O
    Avezum, A
    EUROPEAN HEART JOURNAL, 2002, 23 (15) : 1177 - 1189
  • [2] Complementary and alternative medicine use in patients with coronary artery disease admitted with acute coronary syndromes.
    Narreddy, S
    Barraco, D
    Valencia, G
    Riba, AL
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 : 116 - 117
  • [3] Lesion morphologies of transient no-reflow during percutaneous coronary intervention in acute coronary syndromes. an intravascular ultrasound study
    Iijima, R.
    Shinji, H.
    Wada, M.
    Nakajima, R.
    Nakamura, M.
    EUROPEAN HEART JOURNAL, 2005, 26 : 715 - 715
  • [4] Transradial coronary angioplasty in acute coronary syndromes.
    Ruzsa, Z
    Ungi, I
    Rudas, L
    Thury, A
    Sepp, R
    Horváth, T
    Zimmermann, Z
    Csanády, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (6A): : 173H - 173H
  • [5] Bivalirudin in Acute Coronary Syndromes and Percutaneous Coronary Intervention: Should We Use It?
    Ten, Yuli
    Devlin, Gerard
    HEART LUNG AND CIRCULATION, 2013, 22 (10): : 793 - 800
  • [6] Impact of anemia and mild renal insufficiency in patients undergoing direct percutaneous coronary intervention for acute coronary syndromes.
    Hideki, I
    Iijima, R
    Makino, K
    Shinji, H
    Hara, H
    Tsunoda, T
    Nakamura, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (8A): : 14A - 14A
  • [7] Eptifibatide - A pharmacoeconomic review of its use in percutaneous coronary intervention and acute coronary syndromes
    Plosker, GL
    Ibbotson, T
    PHARMACOECONOMICS, 2003, 21 (12) : 885 - 912
  • [8] EptifibatideA pharmacoeconomic review of its use in percutaneous coronary intervention and acute coronary syndromes
    Greg L. Plosker
    Tim Ibbotson
    PharmacoEconomics, 2003, 21 : 885 - 912
  • [9] Acute Coronary Syndromes: Introduction to Acute Coronary Syndromes. ARC and NZRC Guideline 2011
    EMERGENCY MEDICINE AUSTRALASIA, 2011, 23 (03) : 299 - 301
  • [10] Acute coronary syndromes and coronary intervention
    Luescher, Thomas F.
    EUROPEAN HEART JOURNAL, 2015, 36 (06) : 323 - 324
12345